NCT04865939View on ClinicalTrials.gov

Gemcitabine Versus Water Irrigation in Upper Tract Urothelial Carcinoma

PHASE3RecruitingINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

November 29, 2021

Primary Completion Date

November 1, 2029

Study Completion Date

November 1, 2031

Conditions
Urothelial Cancer of Renal PelvisUrothelial Carcinoma Ureter
Interventions
PROCEDURE

sterile water irrigation

Continuous irrigation of bladder with sterile water during surgery (prior to entry into bladder).

DRUG

Gemcitabine

Intravesical gemcitabine instilled into bladder during surgery (drained prior to entry into bladder).

Trial Locations (1)

75390

RECRUITING

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT04865939 - Gemcitabine Versus Water Irrigation in Upper Tract Urothelial Carcinoma | Biotech Hunter | Biotech Hunter